Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | BGNE | BMRN | ||
| Company | Genmab A/S ADR | Beigene Ltd ADR | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.82 | 192.81 | 85.33 | ||
| High | 27.91 | 193.04 | 86.04 | ||
| Low | 27.46 | 188.52 | 83.73 | ||
| Last | 27.58 | 191.25 | 84.20 | ||
| Change | -0.11 | -0.33 | -0.92 | ||
| % Change | -0.40% | -0.17% | -1.08% | ||
| Volume | 205,280 | 69,957 | 575,361 | ||
| 20-Day Average Volume | 421,071 | 292,900 | 1,532,312 | ||
| Previous Close | 27.69 | 191.58 | 85.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.30 | 192.70 | 90.00 | ||
| 20-Day Raw Stochastic | 78.99% | 44.27% | 0.72% | ||
| 20-Day Relative Strength | 51.82% | 56.99% | 41.76% | ||
| Weighted Alpha | -22.74 | +8.41 | -7.01 | ||
| Today's Opinion | 40% Sell | 72% Buy | 24% Sell | ||
| Previous Opinion | 24% Sell | 72% Buy | Hold | ||
| Last Month's Opinion | 80% Sell | 40% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.95% since 08/29/24 | -4.58% since 08/29/24 | -8.21% since 08/29/24 | ||
| Low | 27.38 on 09/03/24 | 186.03 on 09/04/24 | 83.79 on 09/06/24 | ||
| High | 27.90 on 09/06/24 | 196.37 on 08/30/24 | 92.81 on 09/03/24 | ||
| 1-Month | |||||
| %Chg | +4.06% since 08/06/24 | +10.55% since 08/06/24 | -3.45% since 08/06/24 | ||
| Low | 26.06 on 08/13/24 | 170.36 on 08/07/24 | 83.79 on 09/06/24 | ||
| High | 27.94 on 08/27/24 | 202.59 on 08/27/24 | 94.85 on 08/20/24 | ||
| 3-Month | |||||
| %Chg | -3.52% since 06/06/24 | +20.18% since 06/06/24 | +3.74% since 06/06/24 | ||
| Low | 24.53 on 07/02/24 | 141.31 on 06/27/24 | 80.06 on 08/05/24 | ||
| High | 28.56 on 07/31/24 | 202.59 on 08/27/24 | 94.85 on 08/20/24 | ||
| 6-Month | |||||
| %Chg | -4.56% since 03/06/24 | +18.73% since 03/06/24 | -3.34% since 03/06/24 | ||
| Low | 24.53 on 07/02/24 | 126.97 on 04/19/24 | 73.68 on 05/30/24 | ||
| High | 31.88 on 03/13/24 | 202.59 on 08/27/24 | 94.85 on 08/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,311,370 | 18,564,676 | 16,162,586 | ||
| Shares Outstanding, K | 661,299 | 96,903 | 189,880 | ||
| Annual Sales | 2,392,030,000 | 2,458,780,000 | 2,419,230,000 | ||
| Annual Net Income | 631,910,000 | -881,710,000 | 167,650,000 | ||
| Last Quarter Sales | 779,510,000 | 929,170,000 | 712,030,000 | ||
| Last Quarter Net Income | 203,170,000 | -120,410,000 | 107,170,000 | ||
| 60-Month Beta | 0.99 | 0.61 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.22 on 08/08/24 | -1.15 on 08/07/24 | 0.96 on 08/05/24 | ||
| Latest Earnings Date | 08/08/24 | 08/07/24 | 08/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 22.80 | 0.00 | 50.48 | ||